Jie Min Luo
Chief Executive Officer at AMOY DIAGNOSTICS CO., LTD.
Profile
Jie Min Luo is currently the General Manager & Director at Amoy Diagnostics Co., Ltd.
and a Member-Supervisory Board at SinoPath Medical Investment (Beijing) Co., Ltd.
Jie Min Luo active positions
| Companies | Position | Start |
|---|---|---|
| AMOY DIAGNOSTICS CO., LTD. | Chief Executive Officer | 2021-11-30 |
SinoPath Medical Investment (Beijing) Co., Ltd.
 SinoPath Medical Investment (Beijing) Co., Ltd. Medical/Nursing ServicesHealth Services SinoPath Medical Investment (Beijing) Co., Ltd. engages in the third-party medical diagnostic genetics laboratory. It provides clinical genetic testing, consultation, and advisory services. Its products include cancer detection, remote pathology consultation, hereditary cancer detection, hereditary cardiovascular disease testing, single-gene genetic disease detection, susceptibility gene examination, and immunohistochemistry. The company was founded on June 30, 2013 and is headquartered in Beijing, China. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMOY DIAGNOSTICS CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
SinoPath Medical Investment (Beijing) Co., Ltd.
SinoPath Medical Investment (Beijing) Co., Ltd. Medical/Nursing ServicesHealth Services SinoPath Medical Investment (Beijing) Co., Ltd. engages in the third-party medical diagnostic genetics laboratory. It provides clinical genetic testing, consultation, and advisory services. Its products include cancer detection, remote pathology consultation, hereditary cancer detection, hereditary cardiovascular disease testing, single-gene genetic disease detection, susceptibility gene examination, and immunohistochemistry. The company was founded on June 30, 2013 and is headquartered in Beijing, China. | Health Services |
- Stock Market
- Insiders
- Jie Min Luo
